Effects of Psychosocial Skills Training on Well-Being and Functioning in People With Psychotic Disorders (RUTBE)

November 14, 2026 updated by: Ömer USLU

Effects of Psychosocial Skills Training on Psychological Well-Being and Functioning in Individuals With Chronic Mental Illness: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of psychosocial skills training on psychological well-being and functioning in adults with psychotic disorders. People living with psychotic disorders may experience difficulties in communication, daily activities, social relationships, and maintaining psychological well-being. Psychosocial skills training is designed to help individuals develop practical skills for managing these challenges.

The study will include 34 adults diagnosed with psychotic or schizophrenia spectrum disorders who receive care at a community mental health center in Türkiye. Participants will be randomly assigned to an intervention group (17 participants) or a control group (17 participants).

The intervention group will receive eight weekly, face-to-face group sessions of psychosocial skills training (RUTBE), each lasting approximately 90-120 minutes. The sessions will address communication, problem-solving, understanding mental illness and its treatment, coping with symptoms, managing stress, and improving social and daily living skills. The control group will continue receiving routine care without the additional training during the study period.

Psychological well-being and functioning will be assessed in both groups before the training, immediately after the eight-session program, and three months later. The study will examine whether adding psychosocial skills training to routine mental health care improves psychological well-being and functioning compared with routine care alone.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is designed as a two-arm, parallel-group randomized controlled trial to evaluate the effects of psychosocial skills training on psychological well-being and functioning among individuals with psychotic disorders. The study will be conducted at the Community Mental Health Center affiliated with Söke Fehime Faik Kocagöz State Hospital in Aydın, Türkiye.

A total of 34 participants will be recruited and randomly allocated to an intervention group (n=17) or a control group (n=17) using randomizer.org. Eligible participants will be adults aged 18 years or older who are literate and have a diagnosis of a psychotic or schizophrenia spectrum disorder according to DSM-5 criteria. The treating psychiatrist will assess clinical suitability for participation. Individuals experiencing an acute episode or unable to communicate effectively will be excluded. Written informed consent will be obtained before participation.

The intervention group will receive a structured psychosocial skills training program (RUTBE) based on Liberman's Social and Independent Living Skills Program and the training manual developed by Yıldız. The program will consist of eight weekly, face-to-face group sessions lasting approximately 90-120 minutes each. The sessions will address group preparation and communication, understanding mental illness and daily living skills, cognitive and perceptual disturbances, treatment and medication management, coping with persistent symptoms and early warning signs, avoiding ineffective treatments and substance use, stress management and self-confidence, and improving social functioning. Interactive exercises, role-playing, behavioral rehearsal, feedback, and homework assignments will be used to reinforce skills. Participants may receive homework reminders through telephone calls or messages.

The control group will continue receiving routine mental health care without the additional structured RUTBE program during the intervention and follow-up periods. Following completion of the three-month follow-up assessment, the training will be offered to the control group.

Data will be collected at baseline, immediately after the eight-session intervention, and three months after the intervention. Psychological well-being will be measured using the eight-item Psychological Well-Being Scale, with scores ranging from 8 to 56 and higher scores indicating greater psychological well-being. Functioning will be assessed using the 24-item Functioning Assessment Short Test, with scores ranging from 0 to 72 and higher scores indicating greater functional impairment. A personal information form will be administered at baseline.

The study will compare changes in psychological well-being and functioning between the intervention and control groups over time. The findings may help inform the use of structured psychosocial rehabilitation programs in community mental health services.

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A diagnosis of a psychotic disorder or schizophrenia spectrum disorder according to DSM-5 diagnostic criteria.
  • Ability to read and write.
  • A diagnosis of a bipolar disorder
  • Age 18 years or older.

Exclusion Criteria:

  • Being in the acute phase of the illness.
  • Being unable or unwilling to communicate effectively.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RUTBE Psychosocial Skills Training Group

Participants assigned to the experimental group (n=17) will receive eight weekly, face-to-face group sessions of Ruhsal ve Toplumsal Beceri Eğitimi (RUTBE), a structured psychosocial skills training program, in addition to routine mental health care. Each session will last approximately 90-120 minutes. Psychological well-being and functioning will be assessed at baseline, immediately after the intervention, and three months after the intervention.

RUTBE (Ruhsal ve Toplumsal Beceri Eğitimi) is a structured psychosocial skills training program based on Liberman's Social and Independent Living Skills Program and Yıldız's training manual. The intervention consists of eight weekly, face-to-face group sessions lasting approximately 90-120 minutes each. Session topics include group preparation and communication skills; understanding mental health difficulties and daily living skills; cognitive difficulties and psychotic symptoms; treatment, medications, and side effects; coping with persistent symptoms and recognizing early warning signs; substance-related risks and ineffective treatments; stress management and self-confidence; and social functioning and daily routines. The program incorporates interactive learning, skills practice, and homework assignments, with reminders provided by telephone or messages when needed.

No Intervention: Routine Care Control Group

Participants assigned to the control group (n=17) will continue receiving routine mental health care without additional RUTBE psychosocial skills training during the intervention and follow-up periods. Psychological well-being and functioning will be assessed at baseline, immediately after the eight-week intervention period, and three months later. After completion of the follow-up assessment, the RUTBE program will be offered to control group participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Psychological Well-Being Scale Score
Time Frame: Baseline, immediately after the 8-week intervention, and 3 months after intervention completion

Psychological well-being will be assessed using the eight-item Psychological Well-Being Scale (Flourishing Scale). Each item is scored from 1 to 7, yielding a total score ranging from 8 to 56. Higher scores indicate greater psychological well-being. Changes in total scores will be compared between the intervention and control groups across the three assessment points.

Baseline, immediately after the 8-week intervention, and 3 months after intervention completion
Change in Functioning Assessment Short Test (FAST) Total Score
Time Frame: Baseline, immediately after the 8-week intervention, and 3 months after intervention completion

Functioning will be assessed using the 24-item Functioning Assessment Short Test (FAST). The scale evaluates six domains: autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships, and leisure time. Each item is scored from 0 to 3, yielding a total score ranging from 0 to 72. Higher scores indicate greater functional impairment, while lower scores indicate better functioning. Changes in total scores will be compared between the intervention and control groups across the three assessment points.

Baseline, immediately after the 8-week intervention, and 3 months after intervention completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

November 14, 2026

First Submitted That Met QC Criteria

November 14, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 14, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RUTBE-PATIENT-RCT-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared with other researchers due to the sensitive nature of the clinical and psychosocial information collected from individuals diagnosed with psychotic disorders and the need to protect participant confidentiality and privacy. Study findings will be reported in aggregate form without identifying individual participants.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.